{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:40:13Z","timestamp":1793248813738,"version":"4.5.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2005,7,5]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background\u2014<\/jats:italic>\n            <\/jats:bold>\n            Abnormally elevated blood pressure is the most prevalent risk factor for cardiovascular disease. The large-conductance, voltage- and Ca\n            <jats:sup>2+<\/jats:sup>\n            -dependent K\n            <jats:sup>+<\/jats:sup>\n            (BK) channel has been proposed as an important effector in the control of vascular tone by linking membrane depolarization and local increases in cytosolic Ca\n            <jats:sup>2+<\/jats:sup>\n            to hyperpolarizing K\n            <jats:sup>+<\/jats:sup>\n            outward currents. However, the BK channel may also affect blood pressure by regulating salt and fluid homeostasis, particularly by adjusting the renin-angiotensin-aldosterone system.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods and Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            Here we report that deletion of the pore-forming BK channel \u03b1 subunit leads to a significant blood pressure elevation resulting from hyperaldosteronism accompanied by decreased serum K\n            <jats:sup>+<\/jats:sup>\n            levels as well as increased vascular tone in small arteries. In smooth muscle from small arteries, deletion of the BK channel leads to a depolarized membrane potential, a complete lack of membrane hyperpolarizing spontaneous K\n            <jats:sup>+<\/jats:sup>\n            outward currents, and an attenuated cGMP vasorelaxation associated with a reduced suppression of Ca\n            <jats:sup>2+<\/jats:sup>\n            transients by cGMP. The high level of BK channel expression observed in wild-type adrenal glomerulosa cells, together with unaltered serum renin activities and corticotropin levels in mutant mice, suggests that the hyperaldosteronism results from abnormal adrenal cortical function in BK\n            <jats:sup>\u2212\/\u2212<\/jats:sup>\n            mice.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            These results identify previously unknown roles of BK channels in blood pressure regulation and raise the possibility that BK channel dysfunction may underlie specific forms of hyperaldosteronism.\n          <\/jats:p>","DOI":"10.1161\/01.cir.0000156448.74296.fe","type":"journal-article","created":{"date-parts":[[2005,5,3]],"date-time":"2005-05-03T00:16:14Z","timestamp":1115079374000},"page":"60-68","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":210,"title":["Elevated Blood Pressure Linked to Primary Hyperaldosteronism and Impaired Vasodilation in BK Channel\u2013Deficient Mice"],"prefix":"10.1161","volume":"112","author":[{"given":"Matthias","family":"Sausbier","sequence":"first","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Arntz","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iancu","family":"Bucurenciu","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bo","family":"Zhou","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Sausbier","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Feil","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Kamm","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyrill","family":"Essin","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.","family":"Sailer","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usamah","family":"Abdullah","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Krippeit-Drews","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Feil","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Hofmann","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Gu\u0308nther","family":"Knaus","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kenyon","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Shipston","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan F.","family":"Storm","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Neuhuber","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Korth","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Schubert","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Gollasch","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ruth","sequence":"additional","affiliation":[{"name":"From Pharmakologie und Toxikologie, Pharmazeutisches Institut der Universita\u0308t Tu\u0308bingen, Tu\u0308bingen, Germany (M.S., C.A., I.B., H.Z., U.S., U.A., P.K.-D., P.R.); Institut fu\u0308r Pharmakologie fu\u0308r Pharmazeuten, Universita\u0308tsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany (X.Z., M.K.); Institut fu\u0308r Pharmakologie und Toxikologie der Technischen Universita\u0308t Mu\u0308nchen, Mu\u0308nchen, Germany (S.F., S.K., R.F., F.H.); Helios Franz-Volhard-Klinik, Med Klinik fu\u0308r Nephrologie und Intensivmedizin, MDC fu\u0308r..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.57.2.4017200"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.281.6.H2559"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1373909"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5236.633"},{"key":"e_1_3_3_5_2","first-page":"185","volume":"3","year":"1995","unstructured":"Wallner M, Meera P, Ottolia M, Kaczorowski GJ, Latorre R, Garcia ML, Stefani E, Toro L. Characterization of and modulation by a beta-subunit of a human maxi KCa channel cloned from myometrium. Receptors Channels. 1995; 3: 185\u2013199.","journal-title":"Receptors Channels"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/35038011"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.87.11.e53"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000100068.43006.36"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200420347"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/46816"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000047278.28407.c2"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199911000-00001"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104202200"},{"key":"e_1_3_3_14_2","first-page":"935","volume":"9","year":"1995","unstructured":"Payet MD, Bilodeau L, Drolet P, Ibarrondo J, Guillon G, Gallo-Payet N. Modulation of a Ca(2+)-activated K+ channel by angiotensin II in rat adrenal glomerulosa cells: involvement of a G protein. Mol Endocrinol. 1995; 9: 935\u2013947.","journal-title":"Mol Endocrinol"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401702101"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(80)90050-9"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.2.431"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600228"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.25.11914"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0960313"},{"key":"e_1_3_3_21_2","first-page":"H1147","volume":"272","year":"1997","unstructured":"Schubert R, Serebryakov VN, Mewes H, Hopp HH. Iloprost dilates rat small arteries: role of K(ATP)- and K(Ca)-channel activation by cAMP-dependent protein kinase Am J Physiol. 1997; 272: H1147\u2013H1156.","journal-title":"Am J Physiol"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.87.9.825"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.26.12441"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.11.3045"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200208000-00012"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/35004606"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2000.278.2.C235"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1994.266.5.C1357"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1727"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-123-6-2818"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(01)00384-7"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/377239a0"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/378065a0"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00207.2003"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1089268"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg583"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00241-0"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.10.5463"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.132.3.8382595"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2003"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/107385840100700211"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-24-09585.2001"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.0000156448.74296.FE","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:19:35Z","timestamp":1738829975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.0000156448.74296.FE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7,5]]}},"alternative-id":["10.1161\/01.CIR.0000156448.74296.FE"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.0000156448.74296.fe","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,5]]},"assertion":[{"value":"2005-05-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}